MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma

This publication has 39 references indexed in Scilit:

• Myeloperoxidase (MPO) genotype and lung cancer histologic types: The MPO −463 A allele is associated with reduced risk for small cell lung cancer in smokers
  International Journal of Cancer, 2002
• Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population
  International Journal of Cancer, 2002
• Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk
  American Journal of Industrial Medicine, 2002
• −463 G/A Myeloperoxidase Promoter Polymorphism Is Associated with Clinical Manifestations and the Course of Disease in MPO-ANCA-Associated Vasculitis
  Clinical Immunology, 2002
• Differential effect of oestrogen on post‐exercise cardiac muscle myeloperoxidase and calpain activities in female rats
  Acta Physiologica Scandinavica, 2002
• Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms
  European Journal of Human Genetics, 2001
• Polymorphisms in the SOD2 and HLA-DRB1 Genes Are Associated with Nonfamilial Idiopathic Dilated Cardiomyopathy in Japanese
  Biochemical and Biophysical Research Communications, 1999
• Myeloperoxidase Polymorphism Is Associated with Gender Specific Risk for Alzheimer's Disease
  Experimental Neurology, 1999
• Inhibition of LDL oxidation and myeloperoxidase dependent tyrosyl radical formation by the selective estrogen receptor modulator raloxifene (LY139481 HCL)
  Atherosclerosis, 1996
• Activation of (±)-trans-7, 8-dihydroxy-7, 8-dihydrobenzo[apyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidase
  Carcinogenesis: Integrative Cancer Research, 1991